We welcome the publication of the Welsh Government-commissioned independent review of the governance and accountability arrangements of NHS Wales Shared Services Partnership.
Cardiff Health Partners (CHP), a strategic partnership between Cardiff University, Cardiff and Vale University Health Board and Velindre University NHS Trust, has appointed Rachel Savery as its interim Managing Director.
Velindre Cancer Service colleagues have been recognised for their outstanding contributions to healthcare innovation at last week’s MediWales Innovation Awards.
Accession Therapeutics’ ATTEST trial is a first-in-human Phase 1 trial in solid tumour patients, testing TROCEPT-01 (also known as ATTR-01). The trial is being delivered by Velindre University NHS Trust and Cardiff and Vale University Health Board.